Our Story
From Concept to Reality
TheraB's story began with a spark of inspiration during an engineering design course while our founder was enrolled at Michigan State University.
SnugLit was born from conversations with dozens of mid-Michigan nurses who voiced concerns about outdated jaundice treatments and expressed a need for a solution that prioritizes both mother and baby.
A Brighter Future
Today, TheraB is a venture-backed company dedicated to transforming phototherapy treatment for infants diagnosed with Neonatal Jaundice. In collaboration with our partners, we remain focused on bringing meaningful innovation to the tiniest patients and their families. Together, we are charting a course toward a brighter, connected, healthier future for infants and their families.
*SnugLit is yet not available for purchase. We are currently working with the FDA to obtain clearance as a medical device for sale in the USA.
Supported By Investors Including:
